NO20014966L - Fremstilling av biologisk aktive molekyler - Google Patents

Fremstilling av biologisk aktive molekyler

Info

Publication number
NO20014966L
NO20014966L NO20014966A NO20014966A NO20014966L NO 20014966 L NO20014966 L NO 20014966L NO 20014966 A NO20014966 A NO 20014966A NO 20014966 A NO20014966 A NO 20014966A NO 20014966 L NO20014966 L NO 20014966L
Authority
NO
Norway
Prior art keywords
preparation
biologically active
active molecules
molecules
biologically
Prior art date
Application number
NO20014966A
Other languages
English (en)
Other versions
NO329525B1 (no
NO20014966D0 (no
Inventor
Menachem Rubinstein
Bianling Liu
Daniela Novick
Charles Dinarello
Pierre Graber
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20014966D0 publication Critical patent/NO20014966D0/no
Publication of NO20014966L publication Critical patent/NO20014966L/no
Publication of NO329525B1 publication Critical patent/NO329525B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
NO20014966A 1999-04-13 2001-10-12 Fremgangsmate for fremstilling av et biologisk aktivt cytokin og et cDNA NO329525B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12942799A IL129427A0 (en) 1999-04-13 1999-04-13 Preparation of biologically active molecules
PCT/IL2000/000220 WO2000061768A2 (en) 1999-04-13 2000-04-13 Preparation of biologically active molecules

Publications (3)

Publication Number Publication Date
NO20014966D0 NO20014966D0 (no) 2001-10-12
NO20014966L true NO20014966L (no) 2001-12-11
NO329525B1 NO329525B1 (no) 2010-11-01

Family

ID=11072700

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014966A NO329525B1 (no) 1999-04-13 2001-10-12 Fremgangsmate for fremstilling av et biologisk aktivt cytokin og et cDNA

Country Status (24)

Country Link
US (1) US7098002B1 (no)
EP (1) EP1169460B1 (no)
JP (1) JP4822587B2 (no)
KR (1) KR100682185B1 (no)
CN (1) CN1324140C (no)
AR (1) AR023468A1 (no)
AT (1) ATE326536T1 (no)
AU (1) AU781342B2 (no)
BR (1) BR0009782A (no)
CA (1) CA2368994C (no)
DE (1) DE60028022T2 (no)
DK (1) DK1169460T3 (no)
EA (1) EA006825B1 (no)
EE (1) EE05591B1 (no)
ES (1) ES2259287T3 (no)
HK (1) HK1044351A1 (no)
IL (3) IL129427A0 (no)
MX (1) MXPA01010487A (no)
NO (1) NO329525B1 (no)
PT (1) PT1169460E (no)
SI (1) SI1169460T1 (no)
UA (1) UA73940C2 (no)
WO (1) WO2000061768A2 (no)
ZA (1) ZA200108364B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1336701A (en) * 1999-10-20 2001-04-30 Scios Inc. Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage
US7273722B2 (en) 2000-11-29 2007-09-25 Allergan, Inc. Neurotoxins with enhanced target specificity
SI1392830T1 (sl) 2001-03-08 2006-06-30 Ares Trading Sa Mutanti interlevkina-18, njihova proizvodnja in uporaba
IL142246A0 (en) * 2001-03-26 2002-03-10 Applied Research Systems Method and kit for quantitation of polypeptides
CA2475177A1 (en) 2002-02-11 2003-08-21 Zymogenetics, Inc. Materials and methods for preparing dimeric growth factors
EP1597369B1 (en) * 2003-02-21 2007-10-03 Biotecnol S.A. Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
WO2005017110A2 (en) * 2003-08-06 2005-02-24 University Of Maryland Biotechnology Institute Engineered proteases for affinity purification and processing of fusion proteins
WO2005049847A1 (en) * 2003-11-24 2005-06-02 Novo Nordisk A/S Fusion proteins and methods of cleavage of such proteins
CA2558811A1 (en) 2004-03-08 2005-09-22 Zymogenetics, Inc. Dimeric fusion proteins and materials and methods for producing them
ES2369558T3 (es) * 2005-09-19 2011-12-01 Allergan, Inc. Toxinas clostridiales y toxinas clostridiales activables.
WO2007122975A1 (ja) * 2006-04-20 2007-11-01 Kringle Pharma Inc. Ｈｇｆ前駆体蛋白質改変体及びその活性型蛋白質
DE102007008596B4 (de) * 2007-02-15 2010-09-02 Friedrich-Schiller-Universität Jena Biologisch wirksame Moleküle auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung
CA3128656A1 (en) 2007-08-22 2009-02-26 The Regents Of The University Of California Activatable binding polypeptides and methods of identification and use thereof
WO2009044988A1 (en) * 2007-10-01 2009-04-09 Korea Research Institute Of Bioscience And Biotechnology Method for large scale preparation of procaspases, which can be artificially activated, in e. coli expression system and their activation
DE102009043743B4 (de) 2009-03-13 2016-10-13 Friedrich-Schiller-Universität Jena Zellspezifisch wirksame Moleküle auf Grundlage von siRNA sowie Applikationskits zu deren Herstellung und Verwendung
JP5851842B2 (ja) 2009-01-12 2016-02-03 サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. 改変した抗体組成物、それを作製および使用する方法
AU2010215761B2 (en) * 2009-02-23 2017-04-06 Cytomx Therapeutics, Inc Proproteins and methods of use thereof
CN103923897B (zh) * 2013-01-11 2016-06-01 中国人民解放军军事医学科学院生物工程研究所 caspase重组酶原及其编码基因与应用
CN103388001B (zh) * 2013-07-16 2016-01-20 中国人民解放军第四军医大学 一种含凝血酶切割位点gst膜型表达载体及转染阳性细胞的方法
US10370692B2 (en) 2013-12-20 2019-08-06 Hoffmann-La Roche Inc. Recombinant polypeptide production methods
AU2016243623B2 (en) 2015-03-30 2022-04-14 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
BR112017024610A2 (pt) 2015-06-24 2018-07-31 F. Hoffmann-La Roche Ag anticorpos para receptor antitransferrina com afinidade especificada
AR106189A1 (es) 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
RU2753390C1 (ru) 2015-10-02 2021-08-13 Ф. Хоффманн-Ля Рош Аг Биспецифические антитела к человеческому cd20/человеческому рецептору трансферрина и способы их применения
WO2017176963A1 (en) 2016-04-06 2017-10-12 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
SG11202003192UA (en) 2017-10-11 2020-05-28 Greenlight Biosciences Inc Methods and compositions for nucleoside triphosphate and ribonucleic acid production
KR20200080749A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 N-말단의 메티오닌이 절단된 목적 단백질 발현용 유전자 발현 카세트 및 이를 이용하여 n-말단의 메티오닌이 절단된 목적 단백질을 생산하는 방법
US20230000913A1 (en) * 2019-08-13 2023-01-05 King's College London Immunoresponsive cells armoured with spatiotemporally restricted activity of cytokines of the il-1 superfamily

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000318A1 (en) * 1990-06-25 1992-01-09 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof
US5824297A (en) * 1990-06-25 1998-10-20 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
DE69229252T2 (de) * 1991-08-16 1999-12-16 Merck & Co Inc DNS, welche das Interleukin-1B-Vorläufer-Converting-Enzym kodiert
DE69229126T2 (de) * 1991-12-31 1999-12-30 Zymogenetics Inc Verfahren zur Herstellung von Thrombin
JPH06125784A (ja) * 1992-01-17 1994-05-10 Takeda Chem Ind Ltd モノクローナル抗体，ハイブリドーマ，その製造法および用途
US6303369B1 (en) * 1993-09-30 2001-10-16 Carl Spana Protein expression system
CA2238885A1 (en) * 1995-12-29 1997-07-10 Incyte Pharmaceuticals, Inc. Nucleic acids encoding interferon gamma inducing factor-2
JP4059941B2 (ja) * 1996-08-26 2008-03-12 社団法人芝蘭会 Ｒｈｏ標的タンパク質ｐ１４０ｍＤｉａ
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
JPH10327872A (ja) * 1997-05-30 1998-12-15 Otsuka Pharmaceut Co Ltd Ｂｃｌ−２相互作用蛋白遺伝子ｂｉｓ
AU741138B2 (en) * 1997-08-07 2001-11-22 Toray Industries, Inc. Canine interleukin 18, canine interleukin 1beta convertase, DNA sequences encoding the same, process for producing interleukin 18, and remedies for canine immunological diseases

Also Published As

Publication number Publication date
CA2368994A1 (en) 2000-10-19
HK1044351A1 (en) 2002-10-18
DE60028022D1 (de) 2006-06-22
IL129427A0 (en) 2000-02-17
IL145842A0 (en) 2002-07-25
KR20020007365A (ko) 2002-01-26
WO2000061768A2 (en) 2000-10-19
DK1169460T3 (da) 2006-09-18
AR023468A1 (es) 2002-09-04
EA006825B1 (ru) 2006-04-28
US7098002B1 (en) 2006-08-29
BR0009782A (pt) 2002-01-08
IL145842A (en) 2008-06-05
EE200100530A (et) 2002-12-16
PT1169460E (pt) 2006-07-31
SI1169460T1 (sl) 2006-08-31
ES2259287T3 (es) 2006-10-01
KR100682185B1 (ko) 2007-02-12
EE05591B1 (et) 2012-10-15
JP4822587B2 (ja) 2011-11-24
ATE326536T1 (de) 2006-06-15
MXPA01010487A (es) 2002-05-06
EA200101078A1 (ru) 2002-04-25
CN1353761A (zh) 2002-06-12
AU781342B2 (en) 2005-05-19
UA73940C2 (uk) 2005-10-17
JP2002541813A (ja) 2002-12-10
NO329525B1 (no) 2010-11-01
DE60028022T2 (de) 2006-09-28
CN1324140C (zh) 2007-07-04
EP1169460B1 (en) 2006-05-17
AU3985100A (en) 2000-11-14
NO20014966D0 (no) 2001-10-12
WO2000061768A3 (en) 2001-02-08
EP1169460A2 (en) 2002-01-09
CA2368994C (en) 2010-03-09
ZA200108364B (en) 2002-10-11

Similar Documents

Publication Publication Date Title
NO20014966L (no) Fremstilling av biologisk aktive molekyler
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
PT1239733E (pt) Combinacoes de substancias activas fungicidas
PT1237827E (pt) Preparacao de acelerador de betao
IS5595A (is) Úðagjöf á virkum efnum
ID30233A (id) Antibiotika ketolida
DE60018429D1 (de) Herstellung von poly(trimethylenterephthalat)
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
DE60019960D1 (de) Herstellung von isobutencopolymere
ATE386501T1 (de) Formulierungen von wachstumshormonen
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20016147L (no) Biologiske aktive materialer
DE60028816D1 (de) Herstellung von unipolaren Komponenten
PT1152756E (pt) Derivados de anticonvulsivo uteis no tratamento do autismo
PT1150568E (pt) Combinacoes de substancias activas fungicidas
ID30131A (id) Penggunaan zat penurun kolesterol
DE60016608D1 (de) Herstellung von sulfonylimin-verbindungen
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
DE60007111D1 (de) Herstellung von ausgewählten fluorolefinen
NO20014383L (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20014477D0 (no) Behandling av osteoartritis
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
PT1232141E (pt) Eteres de o-desmetil-venlafaxina
DE60009048D1 (de) Herstellung von norlabdanoxid

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees